February 15, 2026/
Medical overview of childhood cancer, with special emphasis on drug-induced adverse reactions, including the rarely discussed topic of therapy-related secondary cancers, and their management from a pharmacovigilance...
ALVigiLance is a dedicated pharmacovigilance platform designed to support the healthcare team in ensuring safer medication use. Our mission is simple yet vital: to provide trusted insights, practical tools, and up-to-date resources that empower healthcare professionals to identify, prevent, and manage adverse drug reactions (ADRs).
Simplified, practical guides on drug safety and monitoring.
Real-world examples to strengthen your clinical decision-making.
Summaries of global drug warnings and regulatory actions.
Strategies for adverse event reporting, risk management, and patient counseling.
To create a proactive community of healthcare providers who champion medication safety and improve patient outcomes through shared knowledge and vigilance.
Medication safety is everyone’s responsibility. Explore, learn, and engage with ALVigiLance — because together, we can reduce risks and save lives.
Medical overview of childhood cancer, with special emphasis on drug-induced adverse reactions, including the rarely discussed topic of therapy-related secondary cancers, and their management from a pharmacovigilance...
From a pharmacovigilance standpoint, drug-induced anaemia is a significant and often under-recognized adverse drug reaction (ADR). It can occur through various mechanisms, and early detection is...
The Egyptian Drug Authority (EDA) has established a structured framework for managing variations to pharmaceutical products in the post-marketing phase. The document titled Administrative & Relevant Documents...
